QUADRANT CAPITAL GROUP LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,281
-64.4%
119
-61.2%
0.00%
-100.0%
Q2 2023$9,229
-5.3%
307
+14.1%
0.00%0.0%
Q1 2023$9,746
+61.7%
269
+59.2%
0.00%0.0%
Q4 2022$6,028
-66.5%
169
-68.8%
0.00%
-50.0%
Q3 2022$18,000
+350.0%
542
+281.7%
0.00%
+100.0%
Q2 2022$4,0000.0%142
+10.1%
0.00%
Q1 2022$4,0000.0%1290.0%0.00%
Q4 2021$4,0000.0%129
-14.0%
0.00%
-100.0%
Q3 2021$4,0000.0%150
+10.3%
0.00%0.0%
Q2 2021$4,000
+33.3%
136
+5.4%
0.00%
Q1 2021$3,0000.0%1290.0%0.00%
-100.0%
Q4 2020$3,000
+50.0%
129
+19.4%
0.00%
Q3 2020$2,000
-33.3%
1080.0%0.00%
-100.0%
Q2 2020$3,000
+50.0%
1080.0%0.00%
Q1 2020$2,000
+100.0%
108
+77.0%
0.00%
Q4 2019$1,0000.0%610.0%0.00%
Q3 2019$1,000
-96.4%
61
-92.9%
0.00%
-100.0%
Q2 2019$28,000
+1300.0%
858
+1306.6%
0.00%
Q1 2019$2,0000.0%610.0%0.00%
-100.0%
Q4 2018$2,000
-33.3%
610.0%0.00%0.0%
Q3 2018$3,000
-40.0%
61
-38.4%
0.00%
-50.0%
Q2 2018$5,000
+150.0%
99
+62.3%
0.00%
+100.0%
Q1 2018$2,000
-33.3%
61
-41.3%
0.00%0.0%
Q4 2017$3,0000.0%1040.0%0.00%0.0%
Q3 2017$3,000104
+70.5%
0.00%
Q2 2017$0
-100.0%
610.0%0.00%
Q1 2017$1,0000.0%610.0%0.00%
-100.0%
Q4 2016$1,0000.0%61
-57.0%
0.00%0.0%
Q4 2015$1,0000.0%1420.0%0.00%0.0%
Q3 2015$1,0000.0%1420.0%0.00%0.0%
Q2 2015$1,0001420.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders